News > Latest News

Walk News | Sponsor & Foundation News | News in the Parkinson's Disease Community

Sponsor & Foundation News

Voyager Therapeutics Highlights Lead Program VY-AADC for Advanced PD

Voyagerís AADC Gene Therapy Shows Promise as Maintenance Therapy for Parkinsonís Disease

GOCOVRI for Dyskinesia Gets Orphan Drug Designation

Distinguished Movement Disorders Researchers to Lead Fresco Institute at NYU Langone Health

New Phase 3 Trial to Test Nuplazid for Parkinsonís Psychosis in Array of Dementia Patients

Voyager Therapeutics Presents Promising Parkinsonís Data

Adamas Announces FDA Approval of GOCOVRIô as First and Only Medication for the Treatment of Dyskinesia in Parkinsonís Disease Patients

The Michael J. Fox Foundation Announces Award to Drive Phase IIa Clinical Trial Investigating Potential Safety and Benefit of Nilotinib in PD

Forbes Includes Acadia, Maker of Nuplazid on List of Most Innovative Growth Companies

Mitsubishi Buys Israel's NeuroDerm for $1.1B

Participants Invited to Take Survey on Vision and Parkinsonís Disease

US WorldMeds is Now Distributing XADAGO® (Safinamide) in the U.S. for PD Patients

Acorda Submits New Drug Application to U.S. Food and Drug Administration for CVT-301

Adamas Presents Expanded Analysis from the ADS-5102 Open-Label Study

NeuroDerm Presents Six Posters at the 21st International Congress of Parkinsonís Disease and Movement Disorders

Acorda Therapeutics to Present Update on Phase 3 Study of CVT-301 in Parkinsonís Patients

Survey Examines Social Support in Parkinsonís Disease from the Patientís Perspective

UCB Adds Website for its Facebook-based Parkinson's Community

Acorda Expands Alexa Skill Offering for Parkinsonís Awareness Month

Acorda Announces Long-Term Safety Data for CVT-301

FDA Approves Xadago to Treat Parkinsonís Disease

US WorldMeds is Funding Clinical Trial Studying Effectiveness of New Infusion Therapy to Help Smooth Out Movement for Patients with PD

Acorda Announces Positive Phase 3 Clinical Trial Results for CVT-301

LSVT BIG Seminar on Sunday, February 5, 2017 in West Orange, NJ

The Parkinsonís Institute and Clinical Center Awarded $1.9 Million from California Institute for Regenerative Medicine

back to top